In line with these findings, the mRNA level of TLR9 (a member of the TLR family) was reported to increase in the livers of NASH patients and atherogenic diet-fed mouse models.327. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.